T
TMCI
Treace Medical Concepts, Inc.
1.385
+0.045+3.36%Opening15:19 04/08 EDT
OPEN/PREV CLOSE1.410/1.340
TODAY RANGE1.320-1.435
VOL154.25K
MARKET CAP89.73M
52 WEEK RANGE1.170-8.13
AVG VOL (3M)711.97K
% TURNOVER0.24%
TURNOVER--
P/E (TTM)-1.4851
% RANGE8.58%
EPS(TTM)-0.9326
P/E(FORWARD)-1.5220
P/B1.015
BVPS1.364
DIVIDEND--
P/S0.4169
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP64.40M
SHARES OUTSTANDING64.78M
NEXT EARNINGS05/06-05/11
FREE FLOAT46.50M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·03/03 00:10
Treace Medical Earnings Call Balances Progress and Pressure
Dow Jones·03/02 20:41
Treace Medical Concepts Price Target Cut to $7.00/Share From $7.50 by Lake Street
Dow Jones·03/02 20:41
Treace Medical Concepts Is Maintained at Buy by Lake Street
Benzinga·03/02 20:32
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7
TipRanks·03/02 14:26
Treace Medical price target lowered to $2 from $3 at Truist
TipRanks·03/02 14:12
Treace Medical price target lowered to $2.25 from $2.50 at UBS
TipRanks·03/02 13:59
Treace Medical price target lowered to $7 from $7.50 at Lake Street
TipRanks·03/02 13:06
Truist Financial Sticks to Their Hold Rating for Treace Medical Concepts (TMCI)
TipRanks·03/02 12:45
Stifel Nicolaus Sticks to Its Hold Rating for Treace Medical Concepts (TMCI)
Simply Wall St·02/28 06:34
Treace Medical Concepts Q4 Loss Narrowing Challenges Persistent Bearish Narratives On Profitability
Seeking Alpha·02/27 12:28
Treace Medical Concepts GAAP EPS of -$0.15 in-line, revenue of $62.5M beats by $0.63M
Same Industry
Name/Symbol
Change%
Price